Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOCOCIZUMAB vs BOSENTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BOCOCIZUMAB vs BOSENTAN: Safety Overview

Metric BOCOCIZUMAB BOSENTAN
Total FAERS Reports 122 19,581
Deaths Reported 1 4,346
Death Rate 0.8% 22.2%
Hospitalizations 114 8,862
Average Patient Age 61.8 yrs 52.5 yrs
% Female Patients 27.1% 73.2%
FDA Approval Date N/A Apr 26, 2019
Manufacturer N/A Actelion Pharmaceuticals US, Inc.
Route N/A ORAL
Marketing Status N/A Prescription